2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Organoids and 3D Bioprinting in Cancer Models
Organoids and 3D bioprinting represent groundbreaking innovations in cancer research, providing more accurate and dynamic models to study cancer biology. Organoids are miniature, three-dimensional versions of human organs, grown from stem cells, that mimic the tissue structure and function of real tumors. These models allow researchers to study cancer in a more in vivo-like environment, offering insights into tumor growth, drug responses, and metastasis that traditional cell cultures could not provide. 3D bioprinting, on the other hand, enables the creation of customized tumor models by printing living cells layer by layer, facilitating a more precise replication of human cancer. Both technologies offer a more reliable platform for testing potential therapies and understanding the complexity of cancer, thus accelerating the development of personalized medicine and improving treatment strategies.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China